Vaccines

22 Jun 2020 50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II
20 Jun 2020 Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate
18 Jun 2020 Codagenix Announces the Synthesis and Preliminary Safety of Scalable, Live-attenuated Vaccine Candidate Against COVID-19
18 Jun 2020 CureVac Receives Regulatory Approval from German and Belgian Authorities to Initiate Phase 1 Clinical Trial of its SARS-CoV-2 Vaccine Candidate
17 Jun 2020 HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers
17 Jun 2020 PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine
16 Jun 2020 Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
16 Jun 2020 Immunomic Therapeutics Enters into License Agreement with Ichor Medical Systems to Use Electroporation (EP) Delivery Technology in Phase I Study of DNA Vaccine Therapy, ITI-1001
16 Jun 2020 Government-funded Imperial College COVID-19 vaccine moves into first human trials
15 Jun 2020 Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
15 Jun 2020 Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccine
15 Jun 2020 ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine
15 Jun 2020 Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine
14 Jun 2020 AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
14 Jun 2020 Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
13 Jun 2020 Calquence showed long-term efficacy and tolerability for patients with chronic lymphocytic leukaemia in two trials
13 Jun 2020 FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
11 Jun 2020 Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19
11 Jun 2020 Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III
11 Jun 2020 Catalent Partners with Spicona to Develop COVID-19 Vaccine Candidate using GPEx Cell Line Development Platform
10 Jun 2020 Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July
10 Jun 2020 Panacea Biotec and Refana Announce Landmark Collaboration for COVID-19 Vaccine
10 Jun 2020 UbiVac Announces Clinical Trial Collaboration with Bristol Myers Squibb on Combination Immunotherapy for Advanced Triple Negative Breast Cancer
08 Jun 2020 Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
08 Jun 2020 The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top